NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Spiral Therapeutics

Spiral Therapeutics

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.spiraltx.com/

Last Round

Series B

Apr 14, 2026

Total Funding Raised

$32.6M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Spiral Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for inner ear disorders using its proprietary Minimally Invasive Cochlear System (MICS™) drug delivery platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

inner ear disordersdrug delivery platformotolaryngologyhearing losssustained-release drugbiotechnologyclinical-stage biotechcochlear implantblood-labyrinth barrierlocalized therapyhearing therapeuticsent techotology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spiral Therapeutics Comparables

Compare Spiral Therapeutics with similar companies based on industry and business-model similarity.

Spiral Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Acousia Therapeutics GmbH
83%
AudioCure Pharma
80%
Otomagnetics, Inc.
78%

Spiral Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 14, 2026
VC RoundAug 30, 2023
VC RoundJan 9, 2023
Series AMay 6, 2019

Spiral Therapeutics Investors

Notable investors and investment history

Spiral Therapeutics investors
InvestorRounds
Ferring Ventures SASeries B, VC Round
Esperante VenturesVC Round
InvereadySeries A
Savoir CapitalSeries A, VC Round
Catalio Capital ManagementVC Round
Humboldt FundVC Round
EsperanteVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors increased 31% MoM, reaching 1.1K.

  • Apr 14, 2026

    $27M round completed.

Spiral Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Spiral Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Spiral Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range11
Year Founded2016
Last FundingApr 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.